Company / Net Income
Regenerative Medical Technology Group Inc. Net Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$7.8M
FY2025
5-year range
-$12.9M / -$5.5M
FY2021-FY2025
Trend
-40.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 8 years, ranging from -$13M in FY2021 to -$2M in FY2018.
Based on SEC 10-K filings.
-$8M in FY2025.
Improved from -$10M to -$8M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income decreased 40.4% year-over-year.
- Peak net income was recorded in FY2018.
- Lowest net income in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$7.8M | -40.4% |
| FY2024 | -$5.6M | +43.3% |
| FY2023 | -$9.8M | -78.2% |
| FY2022 | -$5.5M | +57.3% |
| FY2021 | -$12.9M | -118.5% |
| FY2020 | -$5.9M | -135.0% |
| FY2019 | -$2.5M | -21.9% |
| FY2018 | -$2.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026